SCHEMBL30106103

SCHEMBL30106103

COC(=O)Cc1cccc(Br)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 3/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
FAAH O00519 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CHRNB2 P17787 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15709960 1.00 ALDH1A1 (0.41) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL17112818 0.89 FAAH (0.38) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL8772200 0.86 ALDH1A1 (0.40) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL23599140 0.83 KDM4E (0.46) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL29502494 0.83 KMT2A (0.46) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL3364540 0.83 KMT2A (0.46) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL15709754 0.83 PSMB5 (0.44) ALDH1A1KDM4ESMN1; SMN2HSD17B10MAPT
SCHEMBL15418113 0.82 MTNR1A (0.39) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL13269959 0.81 NPSR1 (0.42) ALDH1A1HSD17B10HPGDNPC1RAB9A
SCHEMBL12411040 0.81 FAAH (0.37) ALDH1A1SMN1; SMN2HSD17B10HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025226545-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION PRETZEL THERAPEUTICS, INC. (US) 2025-10-30 WO disclosed
US-20230219961-A1 Pyridine acetamide derivative serving as CDK inhibitor, and preparation method therefor and use thereof Suzhou Alphama Biotechnology Co., Ltd. (CN) 2023-07-13 US disclosed
CN-107474024-B Glutaminase inhibitor and composition and application thereof 北京赛林泰医药技术有限公司 2022-12-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219961-A1 Pyridine acetamide derivative serving as CDK inhibitor, and preparation method therefor and use thereof CDK9, CDK7, CDK8 ALDH1A1 1645/4885KDM4E 471/4885SMN1; SMN2 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.